FNY Investment Advisers’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,700	Closed	-$338K	–	730
2018 Q3	$338K	Buy	10,700 +10,200	+2,040%	+$322K	0.08%	143
2018 Q2	$19K	Buy	+500	New	+$19K	0.01%	341